Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Total 13F shares
-
838,423
-
Share change
-
+281,912
-
Total reported value
-
$54,430,898
-
Price per share
-
$64.92
-
Number of holders
-
2
-
Value change
-
+$18,296,727
-
Number of buys
-
2
-
Number of sells
-
1
Institutional Holders of Inari Medical, Inc. - Common Stock, par value $0.001 per share (NARI) as of Q4 2023
As of 31 Dec 2023,
Inari Medical, Inc. - Common Stock, par value $0.001 per share (NARI) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
838,423 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, FRANKLIN RESOURCES INC, ALLIANCEBERNSTEIN L.P., STATE STREET CORP, BROWN ADVISORY INC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, and CREDIT SUISSE AG/.
This page lists
250
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.